Found: 14
Select item for more details and to access through your institution.
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 5, p. 713, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1096>3.0.CO;2-G
- By:
- Publication type:
- Article
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 1, p. 108, doi. 10.1111/j.1365-2141.2012.09139.x
- By:
- Publication type:
- Article
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 6, p. 815, doi. 10.1111/j.1365-2141.2004.05141.x
- By:
- Publication type:
- Article
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992137
- By:
- Publication type:
- Article
Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061603
- By:
- Publication type:
- Article
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 255, doi. 10.1002/cncr.34532
- By:
- Publication type:
- Article
Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 151, doi. 10.1111/bjh.19057
- By:
- Publication type:
- Article
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 54, doi. 10.1111/bjh.18385
- By:
- Publication type:
- Article
Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 82, doi. 10.1111/bjh.18183
- By:
- Publication type:
- Article
T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 548, doi. 10.1111/bjh.17877
- By:
- Publication type:
- Article
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 22, p. 5074, doi. 10.1002/cncr.26182
- By:
- Publication type:
- Article
Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 857, doi. 10.1002/hon.3060
- By:
- Publication type:
- Article
Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 501, doi. 10.1002/hon.2775
- By:
- Publication type:
- Article
Methodological framework for radiomics applications in Hodgkin's lymphoma.
- Published in:
- European Journal of Hybrid Imaging, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41824-020-00078-8
- By:
- Publication type:
- Article